Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  NIPH annals

• Publication date

  1991-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 1812438
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Isolation of human monoclonal antibodies from 4CMenB vaccinees reveals PorB and LOS as the main OMV components inducing cross-strain protection

  2025cites this paper
• Helicobacter pylori Outer Membrane Vesicles: Biogenesis, Composition, and Biological Functions

  2024cites this paper
• Dual-drug loaded manganese dioxide nanoparticles coated with bacterial outer-membrane vesicles for chemo-immunotherapy in lung cancer

  2024cites this paper
• Immunogenicity and Protective Capacity of CpG ODN Adjuvanted Alum Adsorbed Bivalent Meningococcal Outer Membrane Vesicle Vaccine.

  2024cites this paper
• The Two Faces of Bacterial Membrane Vesicles: Pathophysiological Roles and Therapeutic Opportunities

  2023cites this paper
• Emerging role of bacterial outer membrane vesicle in gastrointestinal tract

  2023cites this paper
• OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans

  2023cites this paper
• Synergistic activity of antibodies in the multicomponent 4CMenB vaccine

  2022cites this paper
• Peptide-Based Vaccines for Tuberculosis

  2022cites this paper
• Systematic Evaluation of Kinetics and Distribution of Muscle and Lymph Node Activation Measured by 18F-FDG- and 11C-PBR28-PET/CT Imaging, and Whole Blood and Muscle Transcriptomics After Immunization of Healthy Humans With Adjuvanted and Unadjuvanted Vaccines

  2021cites this paper
• Production and control of a Brazilian tailor-made meningococcal B vaccine

  2021cites this paper
• Stability of Outer Membrane Vesicles-Based Vaccines, Identifying the Most Appropriate Methods to Detect Changes in Vaccine Potency

  2021cites this paper
• Outer membrane vesicles as versatile tools for therapeutic approaches

  2021cites this paper
• Deletion of major porins from meningococcal outer membrane vesicle vaccines enhances reactivity against heterologous serogroup B Neisseria meningitidis strains.

  2020cites this paper
• An assessment of the use of Hepatitis B Virus core protein virus-like particles to display heterologous antigens from Neisseria meningitidis

  2020cites this paper
• Outer membrane vesicle vaccines.

  2020cites this paper
• Measurement of surface protein antigens, PorA and PorB, in Bexsero vaccine using quantitative mass spectrometry.

  2019cites this paper
• Feasibility of Using a Luminescence-Based Method to Determine Serum Bactericidal Activity against Neisseria gonorrhoeae

  2019cites this paper
• The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology

  2019cites this paper
• Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.

  2019cites this paper
• Flagellin-deficient outer membrane vesicles as adjuvant induce cross-protection of Salmonella Typhimurium outer membrane proteins against infection by heterologous Salmonella serotypes.

  2018cites this paper
• Vaccination strategies for the prevention of meningococcal disease

  2018cites this paper
• Bioengineered polyester beads co-displaying protein and carbohydrate-based antigens induce protective immunity against bacterial infection

  2018cites this paper
• High dissolved oxygen tension triggers outer membrane vesicle formation by Neisseria meningitidis

  2018cites this paper
• Impact of meningococcal vaccination on carriage and disease transmission: A review of the literature

  2018cites this paper
• Helicobacter pylori Growth Stage Determines the Size, Protein Composition, and Preferential Cargo Packaging of Outer Membrane Vesicles

  2018cites this paper
• Evaluation of intranasal and subcutaneous route of immunization in neonatal mice using DODAB-BF as adjuvant with outer membrane vesicles of Neisseria meningitis B.

  2018cites this paper
• Procédé amélioré de production de vésicules membranaires externes

  2018cites this paper
• Optimal use of meningococcal serogroup B vaccines: moving beyond outbreak control

  2018cites this paper
• Emerging experience with meningococcal serogroup B protein vaccines

  2017cites this paper
• PRODUCTION OF OUTER MEMBRANE VESCLES OF A GRAM-NEGATIVE BACTERIUM

  2017cites this paper
• Heterogeneity in non‐epitope loop sequence and outer membrane protein complexes alters antibody binding to the major porin protein PorB in serogroup B Neisseria meningitidis

  2017cites this paper
• The Neonatal Immune System: A Unique Host-Microbial Interface

  2017cites this paper
• Glycoengineered Outer Membrane Vesicles as a Platform for Vaccine Development.

  2017cites this paper
• Neisseria cinerea Expresses a Functional Factor H Binding Protein Which Is Recognized by Immune Responses Elicited by Meningococcal Vaccines

  2017cites this paper
• Complement Factor H related proteins and their biological role during bacterial infection

  2017cites this paper
• Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial Vaccines

  2016cites this paper
• Meningococcal Disease in China

  2016cites this paper
• Investigating the regulation of the vaccine antigen Factor H binding protein in Neisseria meningitidis

  2016cites this paper
• C-reactive protein mediated uptake of Neisseria meningitidis into phagocytic cells: the involvement of Fc Gamma receptors and effect on immune responses.

  2016cites this paper
• Fighting Neisseria meningitidis: past and current vaccination strategies

  2016cites this paper
• A Meningococcal Outer Membrane Vesicle Vaccine Incorporating Genetically Attenuated Endotoxin Dissociates Inflammation from Immunogenicity

  2016cites this paper
• Immune responses of a meningococcal A + W outer membrane vesicle (OMV) vaccine with and without aluminium hydroxide adjuvant in two different mouse strains

  2016cites this paper
• Multivalent pIX phage display selects for distinct and improved antibody properties

  2016cites this paper
• Neisseria meningitis GNA1030 is a ubiquinone‐8 binding protein

  2015cites this paper
• A Glimpse on Outer Membrane Vesicles as Vaccine Candidates

  2015cites this paper
• A combined vaccine approach against Vibrio cholerae and ETEC based on outer membrane vesicles

  2015cites this paper
• Regulatory networks of Neisseria meningitidis and their implications for pathogenesis

  2015cites this paper
• Regulatory networks of Neisseria meningitidis and their implications for pathogenesis

  2015cites this paper
• Prevention and control of meningococcal outbreaks: The emerging role of serogroup B meningococcal vaccines.

  2015cites this paper
• A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial

  2015cites this paper
• Limitations of the rabbit pyrogen test for assessing meningococcal OMV based vaccines.

  2015cites this paper
• An OMV Vaccine Derived from a Capsular Group B Meningococcus with Constitutive FetA Expression: Preclinical Evaluation of Immunogenicity and Toxicity

  2015cites this paper
• Understanding and Exploiting Bacterial Outer Membrane Vesicles

  2015cites this paper
• Variability of genes encoding surface proteins used as vaccine antigens in meningococcal endemic and epidemic strain panels from Norway.

  2014cites this paper
• Identification of the immunoproteome of the meningococcus by cell surface immunoprecipitation and MS.

  2014influential citation
• Adjuvant Effects Elicited by Novel Oligosaccharide Variants of Detoxified Meningococcal Lipopolysaccharides on Neisseria meningitidis Recombinant PorA Protein: A Comparison in Mice

  2014cites this paper
• Identification of vaccine antigens using integrated proteomic analyses of surface immunogens from serogroup B Neisseria meningitidis.

  2014cites this paper
• Quantification by LC-MS(E) of outer membrane vesicle proteins of the Bexsero® vaccine.

  2014cites this paper
• Neisseria meningitidis B vaccines: recent advances and possible immunization policies

  2014cites this paper
• Proteomics enabled Vaccinology. Probing Antigen and Epitope Repertoires

  2014cites this paper
• Immunological Study of Responses to a Meningococcal Antigen Using a Multiplex Antibody Binding Assay

  2014cites this paper
• ON TRANSFEROSOMES FOR TRANSDERMAL DRUG DELIVERY 1

  2014cites this paper
• A REVIEW ON TRANSFEROSOMES FOR TRANSDERMAL DRUG DELIVERY

  2014cites this paper
• Roles of bacterial membrane vesicles

  2014cites this paper
• A vaccine against serogroup B Neisseria meningitidis: dealing with uncertainty.

  2014cites this paper
• Bactericidal Antibody Responses Elicited by A Meningococcal Outer Membrane Vesicle Vaccine with Over-Expressed fHbp and Genetically-Attenuated Endotoxin

  2013cites this paper
• Improved Production Process for Native Outer Membrane Vesicle Vaccine against Neisseria meningitidis

  2013influential citation
• Evaluation of Truncated NhhA Protein as a Candidate Meningococcal Vaccine Antigen

  2013cites this paper
• Neisseria meningitidis Protein from Invasive Identification of a Phage-Encoded Ig-Binding

  2013cites this paper
• New versus old meningococcal Group B vaccines: How the new ones may benefit infants & toddlers

  2013cites this paper
• vesicles reduce the endotoxicity and reveal the major protective antigen

  2013cites this paper
• Lipopolysaccharide Modifications of a Cholera Vaccine Candidate Based on Outer Membrane Vesicles Reduce Endotoxicity and Reveal the Major Protective Antigen

  2013cites this paper
• Identification of a Phage-Encoded Ig-Binding Protein from Invasive Neisseria meningitidis

  2013cites this paper
• Cysteine Depletion Causes Oxidative Stress and Triggers Outer Membrane Vesicle Release by Neisseria meningitidis; Implications for Vaccine Development

  2013cites this paper
• Quantitative proteomics reveals distinct differences in the protein content of outer membrane vesicle vaccines.

  2013cites this paper
• Outer Membrane Vesicles as an Acellular Vaccine against Brucellosis

  2013cites this paper
• Serogroup-Specific Interaction of Neisseria meningitidis Capsular Polysaccharide with Host Cell Microtubules and Effects on Tubulin Polymerization

  2013cites this paper
• Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV)

  2013cites this paper
• Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.

  2013cites this paper
• The role of the NadR regulator during infection and its implication for the coverage of a new Meningococcus B vaccine

  2013cites this paper
• Zinc Piracy as a Mechanism of Neisseria meningitidis for Evasion of Nutritional Immunity

  2013cites this paper
• Meningococcal Omp85 in Detergent‐Extracted Outer Membrane Vesicle Vaccines Induces High Levels of Non‐Functional Antibodies in Mice

  2013cites this paper
• Predicted proteins of Neisseria meningitidis as potential vaccine candidates: from in silico analyses to experimental corroboration

  2012cites this paper
• Identification and optimization of critical process parameters for the production of NOMV vaccine against Neisseria meningitidis.

  2012cites this paper
• Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies.

  2012cites this paper
• Outer Membrane Vesicles: Physiological Medical Applications

  2012cites this paper
• The Design of New Adjuvants for Mucosal Immunity to Neisseria meningitidis B in Nasally Primed Neonatal Mice for Adult Immune Response

  2012cites this paper
• Induction of immune responses by purified outer membrane protein complexes from Neisseria meningitidis.

  2012cites this paper
• Outer Membrane Vesicles of Bacteria

  2012cites this paper
• Identification and proposal of a potentially new clonal complex that is a common cause of MenB disease in Central and Eastern Canada.

  2012cites this paper
• History of meningococcal vaccines and their serological correlates of protection.

  2012cites this paper
• The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens.

  2012cites this paper
• Aislamiento de cepas invasivas de Neisseria meningitidis serogrupo sByYe n laciudad de Cumaná, años 2009-2010 Isolation of Invasive Strains of Neisseria meningitides, Serogroups B and Y, in Cumana, 2009-2010

  2012cites this paper
• An Outer Membrane Vesicle Vaccine for Prevention of Serogroup A and W‐135 Meningococcal Disease in the African Meningitis Belt

  2012cites this paper
• A combined approach to assess the potential coverage of a multicomponent protein-based vaccine.

  2012cites this paper
• The Effect of Human Factor H on Immunogenicity of Meningococcal Native Outer Membrane Vesicle Vaccines with Over-Expressed Factor H Binding Protein

  2012cites this paper
• Investigation of Galectin-3 interaction with N. meningitidis and its dimerization with laminin receptor

  2012influential citation
• A novel fusion protein-based vaccine comprising a cell penetrating and immunostimulatory peptide linked to human papillomavirus (HPV) type 16 E7 antigen generates potent immunologic and anti-tumor responses in mice.

  2011cites this paper
• Characterization of Neisseria meningitidis Isolates That Do Not Express the Virulence Factor and Vaccine Antigen Factor H Binding Protein

  2011cites this paper